Palliative Care Needs in Pediatric Hematologic Oncology: Parent-Child Perspectives Across Stages

Xiangyue Jiao1, Junye Jiang2, Ling Yu2

  • 1School of Nursing (X.J., L.C.), Fudan University, Shanghai, China.

Insights

Palliative care needs for children with blood cancers change throughout treatment. Understanding these evolving physical, emotional, and spiritual needs is key for effective family support.

Area of Science:

  • Pediatric Oncology
  • Palliative Care
  • Qualitative Research

Background:

  • Children with hematologic cancers face significant challenges during intensive treatment.
  • Early palliative care is recommended but its evolution in resource-limited settings is understudied.

Purpose of the Study:

  • To describe the changing palliative care needs of pediatric hematologic cancer patients and families.
  • To identify support opportunities tailored to different illness phases.

Main Methods:

  • Descriptive qualitative study using semi-structured interviews with 32 families (53 participants) in China.
  • Explored physical, psychological, social, and spiritual concerns across six illness phases.
  • Inductive content analysis of transcribed interviews.

Main Results:

  • Multidimensional needs shifted across illness trajectory, with symptom burden peaking at diagnosis, intensive therapy, and relapse/end of life.
  • Emotional distress evolved from shock to grief; social strain included academic disruption and caregiver burden.
  • Spiritual concerns like hope and dignity were present throughout, intensifying with advanced illness.

Conclusions:

  • Palliative care needs in pediatric hematologic oncology are phase-specific.
  • Integrating trajectory-informed, culturally responsive primary palliative care can better meet evolving needs and enhance family resilience.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
816